Nova Biomedical Liver Enzyme Blood Measurement Device EP3823530A1
Summary
Nova Biomedical Corporation filed EPO patent application EP3823530A1 for systems and methods measuring liver enzyme levels in blood, covering ALT, AST, ALP, and GGT biomarkers. The application was published on 15 April 2026 with designations extending across 32 EU/EEA states including Germany, France, Italy, Spain, Netherlands, and the United Kingdom. The patent protects point-of-care diagnostic methods and devices for liver enzyme quantification from blood samples.
About this source
GovPing monitors EPO Patent Bulletin - Diagnosis & Surgery (A61B) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 55 changes logged to date.
What changed
EPO published patent application EP3823530A1 for Nova Biomedical Corporation covering systems and methods for measuring liver enzyme levels in blood. The application includes six IPC classifications spanning blood measurement devices (A61B 5/1468, 5/157, 5/00, 5/15) and enzyme assay methods (C12Q 1/00, 1/42, 1/48). Designated states cover all 27 EU member states plus Iceland, Liechtenstein, Norway, Switzerland, Turkey, Serbia, North Macedonia, and Monaco.
Medical device manufacturers and diagnostic developers operating in EU markets should monitor this patent's prosecution progress. Once granted, the patent may affect freedom-to-operate assessments for competitors developing point-of-care liver function testing devices. Inventors named include Jianhong Pei, Joseph Bedard, Yiliyasi Wusimanjiang, Anthony Florindi, and Chung Chang Young.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
SYSTEMS AND METHODS FOR MEASURING LIVER ENZYME LEVELS IN BLOOD
Publication EP3823530A1 Kind: A1 Apr 15, 2026
Applicants
Nova Biomedical Corporation
Inventors
PEI, Jianhong, BEDARD, Joseph, WUSIMANJIANG, Yiliyasi, FLORINDI, Anthony, YOUNG, Chung Chang
IPC Classifications
A61B 5/1468 20060101AFI20220118BHEP A61B 5/157 20060101ALI20220118BHEP A61B 5/00 20060101ALI20220118BHEP A61B 5/15 20060101ALI20220118BHEP C12Q 1/00 20060101ALI20220118BHEP C12Q 1/42 20060101ALI20220118BHEP C12Q 1/48 20060101ALI20220118BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Diagnosis & Surgery (A61B)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Diagnosis & Surgery (A61B) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.